Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemia.

Bertaina A, Zecca M, Buldini B, Sacchi N, Algeri M, Saglio F, Perotti C, Gallina AM, Bertaina V, Lanino E, Prete A, Barberi W, Tumino M, Favre C, Cesaro S, Del Bufalo F, Ripaldi M, Boghen S, Casazza G, Rabusin M, Balduzzi A, Fagioli F, Pagliara D, Locatelli F.

Blood. 2018 Dec 13;132(24):2594-2607. doi: 10.1182/blood-2018-07-861575. Epub 2018 Oct 22.

PMID:
30348653
2.

Identification of a novel HLA-C allele, C*02:10:03, in a Venezuelan patient.

Mazzocco M, Castagnetta M, Bottero F, Garbarino L, Sacchi N.

HLA. 2018 May 17. doi: 10.1111/tan.13299. [Epub ahead of print]

PMID:
29770606
3.

Undermining ribosomal RNA transcription in both the nucleolus and mitochondrion: an offbeat approach to target MYC-driven cancer.

Rossetti S, Wierzbicki AJ, Sacchi N.

Oncotarget. 2017 Dec 22;9(4):5016-5031. doi: 10.18632/oncotarget.23579. eCollection 2018 Jan 12.

4.

Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study.

Milone G, Sacchi N, Gallina A, Leotta S, Picardi A, Guidi S, Tripepi G, Rambaldi A, Bonifazi F.

Bone Marrow Transplant. 2018 Mar;53(3):291-299. doi: 10.1038/s41409-017-0026-z. Epub 2017 Dec 21.

PMID:
29269809
5.

MiR-221-regulated KIT level by wild type or leukemia mutant RUNX1: a determinant of single myeloblast fate decisions that - collectively - drives or hinders granulopoiesis.

Rossetti S, Anauo MJ, Sacchi N.

Oncotarget. 2017 Sep 23;8(49):85783-85793. doi: 10.18632/oncotarget.21266. eCollection 2017 Oct 17.

6.

Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.

Raiola AM, Risitano A, Sacchi N, Giannoni L, Signori A, Aquino S, Bregante S, Di Grazia C, Dominietto A, Geroldi S, Ghiso A, Gualandi F, Lamparelli T, Tedone E, Van Lint MT, Varaldo R, Ibatici A, Marani C, Marotta S, Guolo F, Avenoso D, Garbarino L, Pane F, Bacigalupo A, Angelucci E.

Biol Blood Marrow Transplant. 2018 Jan;24(1):119-126. doi: 10.1016/j.bbmt.2017.10.002. Epub 2017 Oct 9.

PMID:
29024804
7.

The Rome Transplant Network model compared to the Italian Bone Marrow Donor Registry activity for unrelated donor search process and transplant efficiency for hematologic malignancy.

Picardi A, Arcese W, Pollichieni S, Di Piazza F, Mangione I, Gallina AM, Cerretti R, Cudillo L, De Angelis G, Mengarelli A, Dentamaro T, Tirindelli MC, Chierichini A, Ferrari A, Marciano R, Andreani M, Bonifazi F, Sacchi N.

Transfusion. 2017 Jul;57(7):1734-1743. doi: 10.1111/trf.14131. Epub 2017 Jun 13.

PMID:
28608367
8.

Is it time to re-think a sustainable banking model for the Italian Cord Blood Network?

Sacchi N.

Blood Transfus. 2018 May;16(3):221-223. doi: 10.2450/2017.0040-17. Epub 2017 Apr 13. No abstract available.

9.

Validation of the acute leukemia-EBMT score for prediction of mortality following allogeneic stem cell transplantation in a multi-center GITMO cohort.

Shouval R, Bonifazi F, Fein J, Boschini C, Oldani E, Labopin M, Raimondi R, Sacchi N, Dabash O, Unger R, Mohty M, Rambaldi A, Nagler A.

Am J Hematol. 2017 May;92(5):429-434. doi: 10.1002/ajh.24677. Epub 2017 Feb 21.

10.

Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fate.

Rossetti S, Ren M, Visconti N, Corlazzoli F, Gagliostro V, Somenzi G, Yao J, Sun Y, Sacchi N.

Oncotarget. 2016 Dec 27;7(52):87064-87080. doi: 10.18632/oncotarget.13500.

11.

Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.

Rossetti S, Wierzbicki AJ, Sacchi N.

Cell Cycle. 2016 Sep 16;15(18):2515-26. doi: 10.1080/15384101.2016.1215385. Epub 2016 Aug 2.

12.

Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.

Rossetti S, Bshara W, Reiners JA, Corlazzoli F, Miller A, Sacchi N.

Cancer Lett. 2016 Oct 1;380(2):375-83. doi: 10.1016/j.canlet.2016.07.003. Epub 2016 Jul 12.

13.

miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.

Fischer J, Rossetti S, Datta A, Eng K, Beghini A, Sacchi N.

Mol Cancer. 2015 Jan 23;14:7. doi: 10.1186/s12943-014-0283-z.

14.

A registry of HLA-typed donors for production of virus-specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune-compromised patients.

Li Pira G, Ivaldi F, Starc N, Landi F, Rutella S, Locatelli F, Sacchi N, Tripodi G, Manca F.

Transfusion. 2014 Dec;54(12):3145-54. doi: 10.1111/trf.12754. Epub 2014 Jul 20.

PMID:
25041366
15.

Training practices of hematopoietic progenitor cell-apheresis and -cord blood collection staff: analysis of a survey by the Alliance for Harmonisation of Cellular Therapy Accreditation.

Celluzzi CM, Keever-Taylor C, Aljurf M, Koh MB, Rabe F, Rebulla P, Sacchi N, Sanders J, McGrath E, Loper K; Alliance for Harmonisation of Cellular Therapy Accreditation (AHCTA).

Transfusion. 2014 Dec;54(12):3138-44. doi: 10.1111/trf.12753. Epub 2014 Jun 19. Erratum in: Transfusion. 2015 Jun;55(6):1367. Alurf, Mahmoud [corrected to Aljurf, Mahmoud].

PMID:
24947542
16.

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo.

Todisco E, Ciceri F, Oldani E, Boschini C, Micò C, Vanlint MT, Donnini I, Patriarca F, Alessandrino PE, Bonifazi F, Arcese W, Barberi W, Marenco P, Terruzzi E, Cortelazzo S, Santarone S, Proia A, Corradini P, Tagliaferri E, Falcioni S, Irrera G, Dallanegra L, Castagna L, Santoro A, Camboni A, Sacchi N, Bosi A, Bacigalupo A, Rambaldi A.

Leukemia. 2013 Oct;27(10):2086-91. doi: 10.1038/leu.2013.208. Epub 2013 Jul 9. No abstract available.

17.

Quality of harvest and role of cell dose in unrelated bone marrow transplantation: an Italian Bone Marrow Donor Registry-Gruppo Italiano Trapianto di Midollo Osseo Study.

Fagioli F, Quarello P, Pollichieni S, Lamparelli T, Berger M, Benedetti F, Barat V, Marciano R, Rambaldi A, Bacigalupo A, Sacchi N.

Hematology. 2014 Jan;19(1):1-9. doi: 10.1179/1607845413Y.0000000086. Epub 2013 Nov 25.

PMID:
23677141
18.

RUNX1: A microRNA hub in normal and malignant hematopoiesis.

Rossetti S, Sacchi N.

Int J Mol Sci. 2013 Jan 14;14(1):1566-88. doi: 10.3390/ijms14011566. Review.

19.

Identification of an estrogen-regulated circadian mechanism necessary for breast acinar morphogenesis.

Rossetti S, Corlazzoli F, Gregorski A, Azmi NH, Sacchi N.

Cell Cycle. 2012 Oct 1;11(19):3691-700. doi: 10.4161/cc.21946. Epub 2012 Aug 30.

20.

Qualifications and training of adult stem cell donor recruiters: recommendations by the World Marrow Donor Association.

Schmidt AH, Amer B, Halet M, Hildebrand S, Sacchi N.

Bone Marrow Transplant. 2013 Jan;48(1):148-50. doi: 10.1038/bmt.2012.98. Epub 2012 May 28. No abstract available.

PMID:
22635248
21.

Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors.

Signori A, Crocchiolo R, Oneto R, Sacchi N, Sormani MP, Fagioli F, Rambaldi A, Ciceri F, Bacigalupo A.

Bone Marrow Transplant. 2012 Nov;47(11):1474-8. doi: 10.1038/bmt.2012.58. Epub 2012 Apr 2.

PMID:
22465976
22.

Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients.

Rambaldi A, Bacigalupo A, Fanin R, Ciceri F, Bonifazi F, Falda M, Lambertenghi-Deliliers G, Benedetti F, Bruno B, Corradini P, Alessandrino PE, Iacopino P, Arcese W, Scimè R, Raimondi R, Sica S, Castagna L, Lamparelli T, Oneto R, Lombardini L, Pollichieni S, Algarotti A, Carobbio A, Sacchi N, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo, GITMO.

Leukemia. 2012 Aug;26(8):1779-85. doi: 10.1038/leu.2012.55. Epub 2012 Mar 1.

23.

Estimation of human leukocyte antigen class I and class II high-resolution allele and haplotype frequencies in the Italian population and comparison with other European populations.

Rendine S, Ferrero NM, Sacchi N, Costa C, Pollichieni S, Amoroso A.

Hum Immunol. 2012 Apr;73(4):399-404. doi: 10.1016/j.humimm.2012.01.005. Epub 2012 Feb 1.

PMID:
22342872
24.

Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia.

Iori AP, Valle V, Piciocchi A, Meloni G, Torelli GF, Vitale A, Testi AM, Barberi W, Ricci R, Milano F, Lucarelli B, Screnci M, Perrone MP, Laurenti L, Natalino F, Perrone S, Sacchi N, Arcese W, Foà R.

Ann Hematol. 2012 Jun;91(6):941-8. doi: 10.1007/s00277-011-1392-z. Epub 2012 Jan 3.

PMID:
22209945
25.

Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes.

Rossetti S, Esposito J, Corlazzoli F, Gregorski A, Sacchi N.

Cell Cycle. 2012 Jan 15;11(2):350-60. doi: 10.4161/cc.11.2.18792. Epub 2012 Jan 15.

26.

Definitions of histocompatibility typing terms.

Nunes E, Heslop H, Fernandez-Vina M, Taves C, Wagenknecht DR, Eisenbrey AB, Fischer G, Poulton K, Wacker K, Hurley CK, Noreen H, Sacchi N.

Blood. 2011 Dec 1;118(23):e180-3. doi: 10.1182/blood-2011-05-353490. Epub 2011 Oct 14.

27.

Definitions of histocompatibility typing terms: Harmonization of Histocompatibility Typing Terms Working Group.

Nunes E, Heslop H, Fernandez-Vina M, Taves C, Wagenknecht DR, Eisenbrey AB, Fischer G, Poulton K, Wacker K, Hurley CK, Noreen H, Sacchi N; Harmonization of Histocompatibility Typing Terms Working Group.

Hum Immunol. 2011 Dec;72(12):1214-6. doi: 10.1016/j.humimm.2011.06.002. Epub 2011 Jun 15.

28.

Long-lasting protection in brain trauma by endotoxin preconditioning.

Longhi L, Gesuete R, Perego C, Ortolano F, Sacchi N, Villa P, Stocchetti N, De Simoni MG.

J Cereb Blood Flow Metab. 2011 Sep;31(9):1919-29. doi: 10.1038/jcbfm.2011.42. Epub 2011 Apr 6.

29.

Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits.

Brioschi M, Fischer J, Cairoli R, Rossetti S, Pezzetti L, Nichelatti M, Turrini M, Corlazzoli F, Scarpati B, Morra E, Sacchi N, Beghini A.

Neoplasia. 2010 Nov;12(11):866-76.

30.

The conundrum of HLA-DRB1*14:01/*14:54 and HLA-DRB3*02:01/*02:02 mismatches in unrelated hematopoietic SCT.

Pasi A, Crocchiolo R, Bontempelli M, Carcassi C, Carella G, Crespiatico L, Garbarino L, Mascaretti L, Mazzi B, Mazzola G, Miotti V, Porfirio B, Tagliaferri C, Valentini T, Vecchiato C, Fleischhauer K, Sacchi N, Bosi A, Martinetti M.

Bone Marrow Transplant. 2011 Jul;46(7):916-22. doi: 10.1038/bmt.2010.246. Epub 2010 Oct 25.

PMID:
20972469
31.

The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases.

Frassoni F, Varaldo R, Gualandi F, Bacigalupo A, Sambuceti G, Sacchi N, Podestà M.

Best Pract Res Clin Haematol. 2010 Jun;23(2):237-44. doi: 10.1016/j.beha.2010.06.003. Review.

PMID:
20837336
32.

Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.

Hurley CK, Foeken L, Horowitz M, Lindberg B, McGregor M, Sacchi N; WMDA Accreditation and Regulatory Committees.

Bone Marrow Transplant. 2010 May;45(5):819-24. doi: 10.1038/bmt.2010.8. Epub 2010 Feb 22.

PMID:
20173794
33.

Loss of MTG16a (CBFA2T3), a novel rDNA repressor, leads to increased ribogenesis and disruption of breast acinar morphogenesis.

Rossetti S, Hoogeveen AT, Esposito J, Sacchi N.

J Cell Mol Med. 2010 Jun;14(6A):1358-70. doi: 10.1111/j.1582-4934.2009.00982.x. Epub 2009 Dec 2. Erratum in: J Cell Mol Med. 2010 Aug;14(8):2186.

34.

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants.

Bacigalupo A, Lamparelli T, Milone G, Sormani MP, Ciceri F, Peccatori J, Locasciulli A, Majolino I, Di Bartolomeo P, Mazza F, Sacchi N, Pollicheni S, Pinto V, Van Lint MT; Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Bone Marrow Transplant. 2010 Feb;45(2):385-91. doi: 10.1038/bmt.2009.151. Epub 2009 Jul 6.

PMID:
19584823
35.

Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes.

Pasini E, Caggiari L, Dal Maso L, Martorelli D, Guidoboni M, Vaccher E, Barzan L, Franchin G, Gloghini A, De Re V, Sacchi N, Serraino D, Carbone A, Rosato A, Dolcetti R.

Int J Cancer. 2009 Sep 15;125(6):1358-64. doi: 10.1002/ijc.24515.

36.

Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.

Crocchiolo R, Zino E, Vago L, Oneto R, Bruno B, Pollichieni S, Sacchi N, Sormani MP, Marcon J, Lamparelli T, Fanin R, Garbarino L, Miotti V, Bandini G, Bosi A, Ciceri F, Bacigalupo A, Fleischhauer K; Gruppo Italiano Trapianto di Midollo Osseo, Cellule Staminale Ematopoietiche (CSE) e Terapia Cellulare; Italian Bone Marrow Donor Registry.

Blood. 2009 Aug 13;114(7):1437-44. doi: 10.1182/blood-2009-01-200378. Epub 2009 Jun 10.

37.

HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry.

Crocchiolo R, Ciceri F, Fleischhauer K, Oneto R, Bruno B, Pollichieni S, Sacchi N, Sormani MP, Fanin R, Bandini G, Bonifazi F, Bosi A, Rambaldi A, Alessandrino PE, Falda M, Bacigalupo A.

Bone Marrow Transplant. 2009 Nov;44(9):571-7. doi: 10.1038/bmt.2009.67. Epub 2009 Apr 13.

PMID:
19363528
38.

Derangement of a factor upstream of RARalpha triggers the repression of a pleiotropic epigenetic network.

Corlazzoli F, Rossetti S, Bistulfi G, Ren M, Sacchi N.

PLoS One. 2009;4(1):e4305. doi: 10.1371/journal.pone.0004305. Epub 2009 Feb 4.

39.

Cord blood banking.

Brand A, Rebulla P, Engelfriet CP, Reesink HW, Beguin Y, Baudoux E, Kögler G, Ebrahimi M, Grazzini G, Costa AN, Bosi A, Sacchi N, Lombardini L, Pupella S, Lecchi L, Garcidueñas ED, van Beckhoven JM, de Wit HJ, Fibbe WE, Zhiburt EB, Bart T, Beksaç M, Navarrete C, Regan F.

Vox Sang. 2008 Nov;95(4):335-48. doi: 10.1111/j.1423-0410.2008.01106.x. No abstract available.

40.

Novel RNA-binding properties of the MTG chromatin regulatory proteins.

Rossetti S, van Unen L, Sacchi N, Hoogeveen AT.

BMC Mol Biol. 2008 Oct 24;9:93. doi: 10.1186/1471-2199-9-93.

41.

Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study.

Frassoni F, Gualandi F, Podestà M, Raiola AM, Ibatici A, Piaggio G, Sessarego M, Sessarego N, Gobbi M, Sacchi N, Labopin M, Bacigalupo A.

Lancet Oncol. 2008 Sep;9(9):831-9. doi: 10.1016/S1470-2045(08)70180-3. Epub 2008 Aug 8.

PMID:
18693069
42.

Strategies of the donor search for children with second CR ALL lacking a matched sibling donor.

Lanino E, Sacchi N, Peters C, Giardino S, Rocha V, Dini G; EBMT Paediatric, Acute Leukemia Working Parties; Eurocord.

Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S75-9. doi: 10.1038/bmt.2008.59.

PMID:
18545249
43.

Preparation of RNA from tissues and cells.

Ribaudo R, Gilman M, Kingston RE, Choczynski P, Sacchi N.

Curr Protoc Immunol. 2001 May;Chapter 10:Unit 10.11. doi: 10.1002/0471142735.im1011s04. Review.

44.

Preparation of RNA from tissues and cells.

Ribaudo R, Gilman M, Kingston RE, Chomczynski P, Sacchi N.

Curr Protoc Neurosci. 2001 May;Appendix 1:Appendix 1I. doi: 10.1002/0471142301.nsa01is07.

PMID:
18428440
45.

Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.

Sacchi N, Costeas P, Hartwell L, Hurley CK, Raffoux C, Rosenmayr A, Greinix H; Quality Assurance and Clinical Working Groups of the World Marrow Donor Association.

Bone Marrow Transplant. 2008 Jul;42(1):9-14. doi: 10.1038/bmt.2008.76. Epub 2008 Mar 24.

PMID:
18362904
46.

Guanidine methods for total RNA preparation.

Kingston RE, Chomczynski P, Sacchi N.

Curr Protoc Mol Biol. 2001 May;Chapter 4:Unit4.2. doi: 10.1002/0471142727.mb0402s36.

47.

Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus.

De Re V, Caggiari L, De Vita S, Mazzaro C, Lenzi M, Galli M, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Cannizzaro R, Guidoboni M, Dolcetti R.

Dig Liver Dis. 2007 Sep;39 Suppl 1:S65-71.

PMID:
17936227
48.

Role of the HLA class II: HCV-related disorders.

De Re V, Caggiari L, Simula MP, De Vita S, Mazzaro C, Lenzi M, Massimo GM, Monti G, Ferri C, Zignego AL, Gabrielli A, Sansonno D, Dammacco F, Libra M, Sacchi N, Talamini R, Spina M, Tirelli U, Cannizzaro R, Dolcetti R.

Ann N Y Acad Sci. 2007 Jun;1107:308-18.

PMID:
17804559
49.

Disruption of retinoic acid receptor alpha reveals the growth promoter face of retinoic acid.

Somenzi G, Sala G, Rossetti S, Ren M, Ghidoni R, Sacchi N.

PLoS One. 2007 Sep 5;2(9):e836.

Supplemental Content

Loading ...
Support Center